KPIs & Operating Metrics(New)
Growth Metrics

Illumina (ILMN) Research & Development (2016 - 2026)

Illumina filings provide 18 years of Research & Development readings, the most recent being $240.0 million for Q1 2026.

  • On a quarterly basis, Research & Development fell 4.76% to $240.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $955.0 million, a 12.06% decrease, with the full-year FY2025 number at $967.0 million, down 17.28% from a year prior.
  • Research & Development hit $240.0 million in Q1 2026 for Illumina, roughly flat from $239.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $486.0 million in Q1 2023 to a low of $229.0 million in Q3 2025.
  • Median Research & Development over the past 5 years was $323.0 million (2022), compared with a mean of $305.6 million.
  • Biggest five-year swings in Research & Development: skyrocketed 63.96% in 2022 and later decreased 29.84% in 2023.
  • Illumina's Research & Development stood at $325.0 million in 2022, then increased by 4.92% to $341.0 million in 2023, then fell by 24.93% to $256.0 million in 2024, then decreased by 6.64% to $239.0 million in 2025, then grew by 0.42% to $240.0 million in 2026.
  • The last three reported values for Research & Development were $240.0 million (Q1 2026), $239.0 million (Q4 2025), and $229.0 million (Q3 2025) per Business Quant data.